Long-Term Outcome of Enterprise Stenting for Symptomatic ICAS in a High-Volume Stroke Center

Background and Purpose: The Enterprise stent has been used for treating intracranial atherosclerotic stenosis (ICAS), but its long-term outcome remains unclear. The purpose of this study was to evaluate the long-term clinical efficacy of the Enterprise stent used for patients with symptomatic ICAS d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Rongrong, Yan, Long, Kang, Kaijiang, Yang, Ming, Yu, Ying, Mo, Dapeng, Gao, Feng, Wang, Yongjun, Lou, Xin, Miao, Zhongrong, Ma, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248485/
https://www.ncbi.nlm.nih.gov/pubmed/34220681
http://dx.doi.org/10.3389/fneur.2021.672662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248485/
https://www.ncbi.nlm.nih.gov/pubmed/34220681
http://dx.doi.org/10.3389/fneur.2021.672662

Ejemplares similares